Montelukast recalls
The FDA has published 11 recalls involving Montelukast since 2013. The latest was reported on 15 Nov 2023. Most were for manufacturing (cgmp) deviations. Hetero Labs Limited Unit V has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls11since 2013
Last 12 months0reported
Class I19% of total
Ongoing2latest 15 Nov 2023
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 1 9%Class II 7 64%Class III 3 27%
Why montelukast is recalled
Companies
By year
Ongoing montelukast recalls
2 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Montelukast Sodium Tablets, USP, 10 mg recalled | Preferred Pharmaceuticals | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS I | Montelukast Sodium Tablets 10 mg recalled by Hetero Labs Limited Unit VMontelukast Sodium | Hetero Labs Limited Unit V | Packaging Defects | Nationwide |
All montelukast recalls, newest first
11 totalShould you stop taking Montelukast?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.